Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Cancer remains a leading global cause of death, necessitating advanced therapeutic strategies.
• Nanotechnology-based drug delivery systems (NDDSs) show promise for improving chemotherapy efficacy and reducing side effects.
• Current NDDSs often show limited clinical benefits, highlighting the need for further innovation.

Purpose of the Study:

• To review recent advancements in NDDSs for oncology.
• To explore the potential of magnetic nanoparticles (MNPs) to enhance NDDS performance.
• To discuss the challenges and safety considerations of MNP-enhanced NDDSs in cancer treatment.

Main Methods:

• Literature review of nanomedicine and magnetic nanoparticle applications in oncology.
• Analysis of MNP properties and their integration into NDDSs.
• Examination of MNP-enhanced NDDSs' impact on drug targeting, release, and tumor chemoresistance.

Main Results:

• MNPs can improve drug targeting, controlled release, and overcome tumor chemoresistance through magnetic hyperthermia.
• Integrating MNPs into NDDSs offers a promising strategy to augment their therapeutic capabilities.
• Further research is needed to fully realize the clinical potential of MNP-enhanced NDDSs.

Conclusions:

• MNP-enhanced NDDSs represent a significant advancement in nanomedicine for cancer therapy.
• Addressing current challenges and safety concerns is crucial for clinical translation.
• This approach holds potential for revolutionizing cancer treatment outcomes.